Avery Therapeutics, Inc. — Form D
Avery Therapeutics, Inc. of TUCSON, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-01. The offering totals $1.5M, of which $500K was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-06-01
- Form: D
- Accession: 0001708135-17-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $500K
- Remaining: $1.0M
- Minimum investment: $25K
- Investors: 16
- Date of first sale: 2017-05-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-287832
Issuer
- Name: Avery Therapeutics, Inc.
- CIK: 0001708135
- Entity type: Corporation
- Jurisdiction: ARIZONA
- Incorporated: 2015
- Address: 1501 N. CAMPBELL AVE., TUCSON, AZ, 85724
- Phone: 9286077410
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Steven Goldman | Executive Officer | Long Boat Key, FL |
| Jennifer Koevary | Executive Officer | Tucson, AZ |
| Jordan Lancaster | Executive Officer | Tucson, AZ |
More